Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

about

H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome.Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome.

P2860

Q47727637-A7D64138-8291-4F05-9EF1-0FF7D7618AE4 Q48093757-A2B15584-ED89-4A7C-A635-F5D4F3E75125

P2860

Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

Item

http://www.wikidata.org/entity/Q40432262

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

@en

type

Item

label

Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

@en

prefLabel

Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

@en

P1476

Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis

@en

P2093

A Garyphallos

http://www.w3.org/2001/XMLSchema#string

A Koutsonikoli

http://www.w3.org/2001/XMLSchema#string

F Kanakoudi-Tsakalidou

http://www.w3.org/2001/XMLSchema#string

F Papachristou

http://www.w3.org/2001/XMLSchema#string

M Trachana

http://www.w3.org/2001/XMLSchema#string

N Printza

http://www.w3.org/2001/XMLSchema#string

P Pratsidou-Gertsi

http://www.w3.org/2001/XMLSchema#string

V Galanopoulou

http://www.w3.org/2001/XMLSchema#string

V Tzimouli

http://www.w3.org/2001/XMLSchema#string

P2860

Lupus nephritis: the central role of nucleosomes revealed

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis.

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients.

High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.

The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Antigenic heterogeneity of IgA anti-GBM disease: new renal targets of IgA autoantibodies

High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.

Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus

Pathogenesis of lupus nephritis: an update.

P304

79-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEI.12913

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P50

Evangelia Farmaki

P577

2017-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27936517

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5343345

http://www.w3.org/2001/XMLSchema#string

Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

about

P2860

P2860

Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932